tailor-pci and the role of genotype-guided antiplatelet therapy
Published 4 years ago • 856 plays • Length 16:47Download video MP4
Download video MP3
Similar videos
-
47:23
genotype directed antiplatelet therapy, is the time right?
-
1:43
dr. pereira on tailor-pci study - mayo clinic
-
11:05
cyp2c19-guided antiplatelet therapy after pci
-
10:31
entering the twilight zone of dapt duration
-
3:01
antiplatelet therapy post percutaneous coronary intervention by peter m. pollak, md | preview
-
10:40
acc 2021: the tailor-pci follow-up study
-
5:51
acc 2018: anti-platelet therapy in pci - adapt
-
6:10
optimal medication selection for pci procedures
-
8:03
percutaneous coronary intervention in renal transplant recipients
-
2:04
design and results of persist-1 trial of pacritinib for myelofibrosis
-
4:18
percutaneous coronary interventions, anemia, & acute coronary syndrome
-
1:10
mcp 60 seconds with dr naveen pereira on heterogeneity in covid-19
-
6:45
dual anti-platelet therapy: how long after pci, cabg, acs?
-
57:48
center for individualized medicine
-
11:46
acc 21: findings from the host-exam trial
-
0:59
antiplatelet therapy after coronary stenting
-
2:52
shorten antiplatelet therapy after coronary stenting?
-
1:00:29
improving the safety of pci: tribulations, trials, transfusions, and twitter